Cooperative Agreement 7200AA24CA00013
Award Date
10/1/24
Completion Date
9/30/29
Dollars Obligated
$288M
Federal Agency
Office of the Assistant Administrator
Federal Grant Program
98.001
Assistance Type
Cooperative Agreement
Place of Performance
Cambodia
Similar Awards
The U.S. Agency for International Development (USAID) awarded a $4,650,276 Cooperative Agreement under the Foreign Assistance for Programs Overseas (CFDA 98.001) program to JSI Research & Training Institute Inc., a non-profit organization based in Boston, Massachusetts. The agreement, titled "CURE TUBERCULOSIS PROJECT 2", is for a 5-year period from August 2024 to August 2029 and aims to: 1) Improve diagnostic and laboratory network performance to increase tuberculosis (TB) case...
This Cooperative Agreement award, totaling $6,545,200.00, was issued by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program. The award aims to achieve sustainable, equitable, and resilient health systems through locally led, evidence-driven, and context-specific approaches to health system strengthening (HSS), with the goal of advancing primary health care (PHC), accelerating progress toward universal health...
The federal Cooperative Agreement award, with an ID of 72049225CA00002, was granted by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The $6,480,574 award, with a period of performance from January 2025 to January 2030, is intended to support the "TUBERCULOSIS-FREE VISAYAS AND MINDANAO" project implemented by the Tropical Disease Foundation Inc. (TDF), a foreign-owned non-profit organization based in...
This $2,500,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001) aims to improve the tuberculosis (TB) epidemic response in the high-burden northern and central provinces of Mozambique. The award, effective from July 12, 2024 to July 11, 2029, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project seeks to...
This Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, provides $31,253,928 in funding to the Centre For Health Solutions - Kenya, a non-profit organization, to support the Kenyan Ministry of Health in controlling and preventing tuberculosis (TB) over a 5-year period from May 2024 to May 2029. The award will fund comprehensive TB prevention, care, and treatment activities, including...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID), under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program, aims to improve the HIV response and ensure sustained epidemic control in targeted geographic areas of the Democratic Republic of the Congo (DRC). The $2,777,976 award to Family Health International (FHI 360), with a period of performance from October 1, 2024 to September 30, 2027, will support activities to...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $13,095,236 Cooperative Agreement to the World Health Organization (WHO) under the Global Tuberculosis: Developing, Evaluating, Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally program (CFDA 93.494). The award duration is from September 30, 2024 to September 29, 2029. The funding supports WHO's efforts to develop, evaluate, and implement evidence-based and innovative...
The federal Cooperative Agreement award, with ID 72049224CA00003, was issued by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas program (CFDA 98.001). The $6,925,000 award, with a period of performance from Sep 26, 2024 to Sep 25, 2029, supports the USAID/PHILIPPINES TB-FREE LUZON ACTIVITY project. The prime awardee, University Research Co., LLC, will deliver technical assistance and implementation support to strengthen the...
This $7,000,000 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program supports wide-scale interventions to fight tuberculosis (TB) in the Philippines. The project, titled "ACTIONS TO SUPPORT WIDE-SCALE INTERVENTIONS TO FIGHT TB IN THE PHILIPPINES (ACT SWIFT)", will be implemented by the Philippine Tuberculosis Society, Inc. over a 5-year period from October 1, 2024 to September 30,...
The U.S. Agency for International Development (USAID) awarded a $3,595,735 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program to Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), a Dutch non-profit organization. The goal of this 5-year award, titled the Regional Approaches for Eradicating Tuberculosis (RAFET) activity, is to reduce the burden of tuberculosis (TB), particularly drug-resistant TB,...